This white paper sets out the need for adaptive designs in an era of complex, global clinical trials and shows how companies can implement the approaches to accelerate R&D.
This informative podcast will provide a comprehensive examination of the development lifecycle of radionuclide conjugates and antibody-drug conjugates from initial research to clinical application.
Explore regulatory strategies for cell and gene therapies in oncology, focusing on trial design, patient selection, biomarkers, dosing, and safety monitoring to enhance success in early-phase clinical trials.
Discover strategies for success in early-phase hematological oncology trials! This whitepaper covers cohort management, dose selection, and adaptive designs to overcome challenges and drive biotech success.
